Andrew C Harris
Overview
Explore the profile of Andrew C Harris including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
89
Citations
2680
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
21.
Qayed M, Watkins B, Gillespie S, Bratrude B, Betz K, Choi S, et al.
Blood Adv
. 2021 Nov;
6(3):746-749.
PMID: 34753172
No abstract available.
22.
Swain Y, Waller N, Gewirtz J, Harris A
Front Psychiatry
. 2021 Sep;
12:712163.
PMID: 34557118
Individual differences in vulnerability to addiction have been widely studied through factor analysis (FA) in humans, a statistical method that identifies "latent" variables (variables that are not measured directly) that...
23.
Subburaj D, Ng B, Kariminia A, Abdossamadi S, Lauener M, Nemecek E, et al.
Blood
. 2021 Sep;
139(2):287-299.
PMID: 34534280
Chronic graft-versus-host disease (cGVHD) is the most common cause for non-relapse mortality postallogeneic hematopoietic stem cell transplant (HSCT). However, there are no well-defined biomarkers for cGVHD or late acute GVHD...
24.
Harris A
Drug Alcohol Depend
. 2021 Jul;
226:108870.
PMID: 34216863
Background: Establishing preclinical models of the development of nicotine withdrawal following acute nicotine exposure could inform tobacco addiction-related research, treatment, and policy. To this end, this lab has previously reported...
25.
Harris A
Pharmacol Biochem Behav
. 2021 Apr;
205:173185.
PMID: 33831460
Relief from increases in anxiety during nicotine withdrawal contributes to tobacco addiction. While a variety of anxiogenic stimuli elicit avoidance of the center of an open field (thigmotaxis) in rodents,...
26.
Liu S, Gades M, Swain Y, Ramakrishnan A, Harris A, Tran P, et al.
Drug Alcohol Depend
. 2021 Feb;
221:108598.
PMID: 33626484
Background: Opioid abuse is a chronic disorder likely involving stable neuroplastic modifications. While a number of molecules contributing to these changes have been identified, the broader spectrum of genes and...
27.
Swain Y, Gewirtz J, Harris A
Drug Alcohol Depend
. 2021 Feb;
221:108561.
PMID: 33588371
Background: Like other forms of psychopathology, vulnerability to opioid addiction is subject to wide individual differences. Animal behavioral models are valuable in advancing our understanding of mechanisms underlying vulnerability to...
28.
Watkins B, Qayed M, McCracken C, Bratrude B, Betz K, Suessmuth Y, et al.
J Clin Oncol
. 2021 Jan;
39(17):1865-1877.
PMID: 33449816
Purpose: Severe (grade 3-4) acute graft-versus-host disease (AGVHD) is a major cause of death after unrelated-donor (URD) hematopoietic cell transplant (HCT), resulting in particularly high mortality after HLA-mismatched transplantation. There...
29.
Harris A, Muelken P, Lesage M
Pharmacol Biochem Behav
. 2020 Sep;
198:173041.
PMID: 32926882
Identifying novel constituents that contribute to tobacco addiction is essential for developing more effective treatments and informing FDA regulation of tobacco products. While preclinical data indicate that monoamine oxidase (MAO)...
30.
Swain Y, Muelken P, Skansberg A, Lanzdorf D, Haave Z, Lesage M, et al.
Psychopharmacology (Berl)
. 2020 May;
237(8):2279-2291.
PMID: 32388620
Rationale: Understanding factors contributing to individual differences in vulnerability to opioid addiction is essential for developing more effective preventions and treatments, yet few reliable behavioral predictors of subsequent opioid self-administration...